Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma

Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated...

Full description

Bibliographic Details
Main Authors: Urpu Salmenniemi, Kari Remes
Format: Article
Language:English
Published: MDPI AG 2012-06-01
Series:Hematology Reports
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/4001
_version_ 1797936656648503296
author Urpu Salmenniemi
Kari Remes
author_facet Urpu Salmenniemi
Kari Remes
author_sort Urpu Salmenniemi
collection DOAJ
description Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
first_indexed 2024-04-10T18:32:43Z
format Article
id doaj.art-0c46401806664ec998d546b153e5d836
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:32:43Z
publishDate 2012-06-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-0c46401806664ec998d546b153e5d8362023-02-02T02:36:19ZengMDPI AGHematology Reports2038-83222038-83302012-06-0142e13e1310.4081/hr.2012.e132192Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myelomaUrpu Salmenniemi0Kari Remes1Turku University Hospital, Mepartment of MedicineTurku University Hospital, Department of MedicineThrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.http://www.pagepress.org/journals/index.php/hr/article/view/4001Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, multiple myeloma
spellingShingle Urpu Salmenniemi
Kari Remes
Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
Hematology Reports
Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, multiple myeloma
title Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_full Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_fullStr Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_full_unstemmed Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_short Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
title_sort thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
topic Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, multiple myeloma
url http://www.pagepress.org/journals/index.php/hr/article/view/4001
work_keys_str_mv AT urpusalmenniemi thromboticmicroangiopathyassociatedwithbortezomibtreatmentinapatientwithrelapsedmultiplemyeloma
AT kariremes thromboticmicroangiopathyassociatedwithbortezomibtreatmentinapatientwithrelapsedmultiplemyeloma